Nasdaq Copenhagen

Citi Appointed as Successor Depositary Bank for Nordea Bank Abp’s ADR Programme

Retrieved on: 
Thursday, January 12, 2023
Banking, Professional Services, Finance, Nasdaq Copenhagen, Nasdaq Stockholm, OTC, Swanson v. Citibank N.A., Nasdaq Helsinki, ADR, Nordea, Citibank, Security (finance), Citigroup

Citi, acting through Citibank N.A., has been appointed by Nordea Bank Abp (“Nordea”) to act as successor depositary bank for its sponsored Level 1 American Depositary Receipt (“ADR”) programme.

Key Points: 
  • Citi, acting through Citibank N.A., has been appointed by Nordea Bank Abp (“Nordea”) to act as successor depositary bank for its sponsored Level 1 American Depositary Receipt (“ADR”) programme.
  • Nordea’s ADR programme trades in the US over-the-counter (OTC) market under the symbol “NRDBY”.
  • Nordea’s underlying ordinary shares are listed and trade on the Nasdaq Helsinki, Nasdaq Stockholm and Nasdaq Copenhagen stock exchanges under the symbol “NDA”.
  • Commenting on the appointment, Dirk Jones, Global Head of Issuer Services, at Citi said: “I am delighted on behalf of Citi that we have been selected by Nordea Bank as successor ADR depositary bank for its sponsored Level 1 ADR programme.

Jabra showcases true wireless expertise for consumers, enterprise and medical at CES 2023

Retrieved on: 
Wednesday, January 4, 2023
OTC, Zoom, Hearing loss, Nasdaq Copenhagen, Music, LAS, SVP, Hearing, Microsoft, FDA, Hybrid, GN, Digital feedback reduction, CES, Operations Enhance and Enhance Plus, Multimedia, ANC, Noise, Ear, Kool-Aid, Algorithm, Human, Noise reduction, Qualcomm, DKK, Video game console, Consumer electronics, Mobile phone, Cassette tape, Online shopping, Elite, Jabra

Jabra Enhance Plus , offered in the new over-the-counter hearing aid category, enables hearing enhancement, music and calls in a miniaturized true wireless form factor.

Key Points: 
  • Jabra Enhance Plus , offered in the new over-the-counter hearing aid category, enables hearing enhancement, music and calls in a miniaturized true wireless form factor.
  • Jabra Enhance Plus delivers a 3-in-1 experience in a miniaturized true wireless form factor design, around half the size of Jabra's smallest true wireless earbuds.
  • Calum MacDougall, SVP at Jabra said, "We are delighted to be back in Las Vegas to showcase the newest products in our true wireless line-up.
  • The Jabra Elite 5 ($149), Jabra Evolve2 Buds ($269) and Jabra Enhance Plus ($799), are available at selected retailers.

BioPorto adds Mr. Nis Kruse as EVP of Strategic Partnerships and GM of EMEA & APAC

Retrieved on: 
Monday, December 5, 2022
Merck & Co., SVP, Aarhus University, Growth, Policy, Lundbeck, COVID, Food, US Foods, FDA, Business, Christian Democrats/EVP/glp Group, Acute kidney injury, AstraZeneca, De novo, Nasdaq Copenhagen, Merck, Quality of life, Mortality, Family, Northstar Commercial Partners, News, AKI, CPH, Agilent Technologies, Biomarker, NGAL, University, Patient, CE, Physician, Antibody, Disease, Infection, Risk assessment, Risk, Partnership, EVP, Medical device, Pharmaceutical industry, Economics, Hellerup

COPENHAGEN, Denmark and BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today announced that Mr. Nis Kruse joined the Company as EVP of Strategic Partnerships and General Manager of EMEA & APAC.

Key Points: 
  • COPENHAGEN, Denmark and BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today announced that Mr. Nis Kruse joined the Company as EVP of Strategic Partnerships and General Manager of EMEA & APAC.
  • Earlier in his career, Mr. Kruse held leadership roles in Copenhagen at Agilent Technologies, H. Lundbeck, and AstraZeneca.
  • Mr. Kruse holds Master’s and Bachelor’s degrees in Economics and Business Management from University of Aarhus (Denmark).
  • “I am excited to join BioPorto at this key juncture in advancing NGAL tests into routine clinical use,” remarked Mr. Kruse.

Ørsted’s financial calendar 2023

Retrieved on: 
Friday, November 11, 2022
Targets, Farm, Corporate Knights, Nasdaq Copenhagen, Science, EUR, Biodiversity, Wind, Renewable energy, Facebook

The rsted vision is a world that runs entirely on green energy.

Key Points: 
  • The rsted vision is a world that runs entirely on green energy.
  • rsted develops, constructs, and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities, and bioenergy plants.
  • Moreover, rsted provides energy products to its customers.
  • rsted's shares are listed on Nasdaq Copenhagen (Orsted).

BioPorto Announces Interim Results for the First Nine Months of 2022

Retrieved on: 
Wednesday, November 9, 2022
Quality of life, Income, Forward-looking statement, NOTE, Risk, Nasdaq Copenhagen, CE, Disease, Mortality, Acute kidney injury, Annual report, Antibody, News, Risk assessment, Policy, Biomarker, Company, AKI, Patient, Physician, NGAL, Industry, FDA, Medical device, Pharmaceutical industry

COPENHAGEN, Denmark and BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced interim financial results for the first nine months of 2022 and business progress for the third quarter of 2022.

Key Points: 
  • The shares of BioPorto A/S are listed on the Nasdaq Copenhagen stock exchange.
  • Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements.
  • NOTE DKK/USD exchange rates used within Recent Highlights, above:
    Balance sheet measures: September 30, 2021 = 6.4220 and September 30, 2022 = 7.6287
    Income statement measures for nine months ended: September 30, 2021 = 6.1842 and September 30, 2022 = 6.9144.
  • Income statement measures for third quarter ended: September 30, 2021 = 6.2690 and September 30, 2022 = 7.3067.

Lively is now JabraEnhance.com - an online destination for better hearing

Retrieved on: 
Monday, November 7, 2022
Hearing, Time of Our Lives/Connected, Kool-Aid, Multimedia, GN, Miniaturization, SteelSeries, OTC, Senior, The Legend of Heroes, CEO, Nasdaq Copenhagen, Ear, View, Topical steroid withdrawal, Life, ReSound, Engineering, Acquisition, Hearing loss, Technology, Personality, Wireless, Sound, Solution, Music, Pharmaceutical industry, Dentistry, Mobile phone, Online shopping, Facebook, Lively, Jabra, Beltone

Lively has rebranded to Jabra Enhance and launched a new website, JabraEnhance.com , as an online destination for better hearing enabling consumers to explore, purchase and receive hearing care from home.The rebrand follows GN's acquisition of Lively in 2021 to expand offerings in the fast-growing telehealth market.

Key Points: 
  • Lively has rebranded to Jabra Enhance and launched a new website, JabraEnhance.com , as an online destination for better hearing enabling consumers to explore, purchase and receive hearing care from home.The rebrand follows GN's acquisition of Lively in 2021 to expand offerings in the fast-growing telehealth market.
  • "Whether you need a hearing enhancing earbud, a stand-alone OTC hearing aid, or professional programming and support, the Jabra Enhance offering will cover the hearing needs for millions of Americans, with an easy online destination to explore, purchase and receive care."
  • Lively has been a leader in the telehealth hearing care space, helping tens of thousands of customers hear better with our innovative online care model.
  • In connection with the rebrand, Lively Hearing Corporation changed its name to GN Consumer Hearing Corporation, doing business as Jabra Enhance.

BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call

Retrieved on: 
Thursday, November 3, 2022
AKI, Company, Mortality, CE, Antibody, Biomarker, Disease, Quality of life, Risk assessment, Nasdaq Copenhagen, Physician, Risk, Acute kidney injury, Patient, NGAL, Pharmaceutical industry

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers tools designed to help clinicians make changes in patient management.

Key Points: 
  • BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers tools designed to help clinicians make changes in patient management.
  • The NGAL Test is CE marked and registered in a number of countries worldwide.
  • BioPorto has facilities in Copenhagen, Denmark and Boston, MA, USA.
  • The shares of BioPorto A/S are listed on the Nasdaq Copenhagen stock exchange.

Release date of nine-month interim report (Q3) 2022 for ALK and audio cast

Retrieved on: 
Thursday, November 3, 2022
CET, Nasdaq Copenhagen, Management, Immunotherapy, Asthma, Allergy, OMX, ALK

On Thursday, 10 November 2022, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its nine-month interim report (Q3) 2022.

Key Points: 
  • On Thursday, 10 November 2022, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its nine-month interim report (Q3) 2022.
  • ALK will host a meeting for analysts and institutional investors that day at 1.30 pm (CET) at which Management will review the financial results, the outlook and answer questions.
  • The meeting will be audio cast live on our website https://ir.alk.net, where the related presentation will be available shortly before the meeting begins.
  • Headquartered in Hrsholm, Denmark, ALK employs around 2,600 people worldwide and is listed on Nasdaq Copenhagen.

Ørsted to present results for the first nine month of 2022 on 3 November

Retrieved on: 
Friday, October 28, 2022
Corporate Knights, Farm, Biodiversity, Nasdaq Copenhagen, LinkedIn, EUR, Instagram, Wind, Twitter, Science, Targets, Renewable energy, Facebook

The rsted vision is a world that runs entirely on green energy.

Key Points: 
  • The rsted vision is a world that runs entirely on green energy.
  • rsted develops, constructs, and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities, and bioenergy plants.
  • Moreover, rsted provides energy products to its customers.
  • In 2021, the group's revenue was DKK 77.7 billion (EUR 10.4 billion).

Jabra unveils professional, pocketable true wireless earbuds engineered for hybrid and remote working

Retrieved on: 
Tuesday, October 25, 2022
Adjustable-focus eyeglasses, ANC, MSRP, Zoom, Human voice, Research, Music, Multimedia, Microsoft, Technology, SVP, GN, DKK, Nasdaq Copenhagen, Noise, Sound, Coffee, Freedom, View, Algorithm, Video game, Mobile phone, Palm sugar, Jabra

In an age where hybrid working is standard for most professionals, having the freedom and flexibility to work from anywhere is important.

Key Points: 
  • In an age where hybrid working is standard for most professionals, having the freedom and flexibility to work from anywhere is important.
  • The top-of-the-range, new Evolve2 Buds are designed to boost concentration and improve collaboration for professionals working on the go.
  • With many of us now used to the true wireless earbud form factor, Jabra developed the Evolve2 Buds to enable users to have high-quality conversations with Jabra MultiSensor Voice.
  • Jabra is a world leading brand in audio, video, and collaboration solutions engineered to empower consumers and businesses.